In addition, it is possible that the presence of CHIP reflects a general risk not only for CHIP-derived, but also for other myeloid neoplasms (de novo vs. CHIP-derived MDS) or other cancers. This evidence concerns the gene STUB1 and myelodysplastic syndrome.